The interaction of nemorubicin metabolite PNU-159682 with DNA fragments d(CGTACG)(2), d(CGATCG)(2) and d(CGCGCG)(2) shows a strong but reversible binding to G:C base pairs.

Abstract

The antitumor anthracycline nemorubicin is converted by human liver microsomes to a major metabolite, PNU-159682 (PNU), which was found to be much more potent than its parent drug toward cultured tumor cells and in vivo tumor models. The mechanism of action of nemorubicin appears different from other anthracyclines and until now is the object of studies. In fact PNU is deemed to play a dominant, but still unclear, role in the in vivo antitumor activity of nemorubicin. The interaction of PNU with the oligonucleotides d(CGTACG)(2), d(CGATCG)(2) and d(CGCGCG)(2) was studied with a combined use of (1)H and (31)P NMR spectroscopy and by ESI-mass experiments. The NMR studies allowed to establish that the intercalation between the base pairs of the duplex leads to very stable complexes and at the same time to exclude the formation of covalent bonds. Melting experiments monitored by NMR, allowed to observe with high accuracy the behaviour of the imine protons with temperature, and the results showed that the re-annealing occurs after melting. The formation of reversible complexes was confirmed by HPLC-tandem mass spectra, also combined with endonuclease P1digestion. The MS/MS spectra showed the loss of neutral PNU before breaking the double helix, a behaviour typical of intercalators. After digestion with the enzyme, the spectra did not show any compound with PNU bound to the bases. The evidence of a reversible process appears from both proton and phosphorus NOESY spectra of PNU bound to d(CGTACG)(2) and to d(CGATCG)(2). The dissociation rate constants (k(off)) of the slow step of the intercalation process, measured by (31)P NMR NOE-exchange experiments, showed that the kinetics of the process is slower for PNU than for doxorubicin and nemorubicin, leading to a 10- to 20-fold increase of the residence time of PNU into the intercalation sites, with respect to doxorubicin. A relevant number of NOE interactions allowed to derive a model of the complexes in solution from restrained MD calculations. The conformation of PNU bound to the oligonucleotides was also derived from the coupling constant values.

• Authors: Stefania Mazzini, Leonardo Scaglioni, Rosanna Mondelli, Michele Caruso, Federico Riccardi Sirtori
• Journal: Bioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 20 Issue 24 Pg. 6979-88 (Dec 15 2012) ISSN: 1464-3391 [Electronic] England
• PMID: 23154079 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2012 Elsevier Ltd. All rights reserved.

Chemical References

• 3'-deamino-3'',4'-anhydro-(2''-methoxy-3''-oxy-4''-morpholinyl)doxorubicin
• Antibiotics, Antineoplastic
• Oligonucleotides
• Topoisomerase II Inhibitors
• Guanine
• Doxorubicin
• Cytosine
• DNA

Topics

• Antibiotics, Antineoplastic (chemistry, metabolism, pharmacology)
• Base Pairing
• Cytosine (chemistry, metabolism)
• DNA (chemistry, drug effects, metabolism)
• Doxorubicin (analogs & derivatives, chemistry, metabolism, pharmacology)
• Guanine (chemistry, metabolism)
• Humans
• Magnetic Resonance Spectroscopy
• Models, Molecular
• Oligonucleotides (chemistry, metabolism)
• Spectrophotometry, Ultraviolet
• Thermodynamics
• Topoisomerase II Inhibitors (chemistry, metabolism, pharmacology)